Diagnosing Type 1 diabetes in adults: Guidance from the UK T1D Immunotherapy consortium
Diabet Med
.
2022 Jul;39(7):e14862.
doi: 10.1111/dme.14862.
Epub 2022 May 6.
Authors
Danijela Tatovic
1
,
Angus G Jones
2
,
Carol Evans
3
,
Anna E Long
4
,
Kathleen Gillespie
4
,
Rachel E J Besser
5
,
Richard David Leslie
6
,
Colin M Dayan
1
5
;
Type 1 diabetes UK Immunotherapy Consortium
Affiliations
1
Cardiff University, Cardiff, UK.
2
Exeter University, Exeter, UK.
3
University Hospital Wales, Cardiff, UK.
4
University of Bristol, Bristol, UK.
5
University of Oxford, Oxford, UK.
6
University of London, London, UK.
PMID:
35488476
PMCID:
PMC9320853
DOI:
10.1111/dme.14862
No abstract available
Publication types
Letter
MeSH terms
Adult
Diabetes Mellitus, Type 1* / diagnosis
Diabetes Mellitus, Type 1* / therapy
Diabetes Mellitus, Type 2*
Genetic Predisposition to Disease
Humans
Immunotherapy
United Kingdom / epidemiology